Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports

We report on two HIV-1 infected patients in which the historical genotype showed mutations against all the major drug classes and in which viral suppression has been obtained by non-conventional antiretroviral therapy regimens, including the combination of darunavir at high dosage (800 mg bid), dolutegravir (50 mg bid) and a third agent, i.e. enfuvirtide in the first case and etravirine in the second one.

Source: International Journal of STD and AIDS - September 22, 2015 Category: Global & Universal Authors: Taramasso, L., Dentone, C., Alessandrini, A., Bruzzone, B., Icardi, G., Garraffo, R., De Macina, I., Viscoli, C., Di Biagio, A., HIV/HCV Collaborative Liguria Group Tags: Case reports Source Type: research